- Home
- KLIC vs BEAM Comparison
KLIC vs BEAM Comparison
Compare KLIC & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLIC
- BEAM
- Stock Information
- Founded
- KLIC 1951
- BEAM 2017
- Country
- KLIC United States
- BEAM United States
- Employees
- KLIC N/A
- BEAM N/A
- Industry
- KLIC Semiconductors
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KLIC Technology
- BEAM Health Care
- Exchange
- KLIC Nasdaq
- BEAM Nasdaq
- Market Cap
- KLIC 2.4B
- BEAM 1.9B
- IPO Year
- KLIC N/A
- BEAM 2020
- Fundamental
- Price
- KLIC $42.69
- BEAM $25.26
- Analyst Decision
- KLIC Strong Buy
- BEAM Buy
- Analyst Count
- KLIC 5
- BEAM 10
- Target Price
- KLIC $52.40
- BEAM $47.67
- AVG Volume (30 Days)
- KLIC 378.9K
- BEAM 1.1M
- Earning Date
- KLIC 02-04-2025
- BEAM 02-25-2025
- Dividend Yield
- KLIC 1.41%
- BEAM N/A
- EPS Growth
- KLIC N/A
- BEAM N/A
- EPS
- KLIC N/A
- BEAM N/A
- Revenue
- KLIC $706,232,000.00
- BEAM $349,643,000.00
- Revenue This Year
- KLIC $10.37
- BEAM N/A
- Revenue Next Year
- KLIC $17.29
- BEAM $14.08
- P/E Ratio
- KLIC N/A
- BEAM N/A
- Revenue Growth
- KLIC N/A
- BEAM 328.73
- 52 Week Low
- KLIC $38.20
- BEAM $20.84
- 52 Week High
- KLIC $53.71
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- KLIC 30.25
- BEAM 47.25
- Support Level
- KLIC $42.28
- BEAM $22.50
- Resistance Level
- KLIC $46.07
- BEAM $26.88
- Average True Range (ATR)
- KLIC 1.28
- BEAM 1.64
- MACD
- KLIC -0.39
- BEAM 0.11
- Stochastic Oscillator
- KLIC 5.83
- BEAM 46.86
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.